Emilie Scientific is a company offering a software platform with advanced data analytics for optimizing clinical trial research that is headquartered in New York City, New York and was founded in 2018 by Sam Holliday.
The Emilie Scientific clinical trial platform creates intelligent connections using data between physicians, researchers, clinical operation experts, and patients to improve the efficiency of clinical trials. The platform offers patient targeting, conversion, and recruitment services and also provides electronic consent for patients and clinical trial sites. Emilie Scientific is able to provide target outreach to patients based on their interest and needs while providing an eligibility user interface to determine if a patient qualifies for a clinical trial. After identifying patients for clinical trials Emilie Scientific provides and educational platform for each patient to inform them about the clinical trial they are participating in and offer them an option to give electronic consent.
Company
Healthcare
New York City